A detailed history of Exane Derivatives transactions in Maxcyte, Inc. stock. As of the latest transaction made, Exane Derivatives holds 502 shares of MXCT stock, worth $2,063. This represents 0.0% of its overall portfolio holdings.

Number of Shares
502
Holding current value
$2,063
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

BUY
$3.59 - $6.81 $1,802 - $3,418
502 New
502 $2,000
Q1 2022

Apr 22, 2022

SELL
$5.26 - $10.84 $143,634 - $296,007
-27,307 Closed
0 $0
Q4 2021

Jan 28, 2022

SELL
$8.87 - $12.94 $56,457 - $82,363
-6,365 Reduced 18.9%
27,307 $278,000
Q3 2021

Oct 26, 2021

BUY
$12.21 - $17.2 $411,135 - $579,158
33,672 New
33,672 $411,000

Others Institutions Holding MXCT

About MAXCYTE, INC.


  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $418M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.